Swiss LithoClast Trilogy
K-Number: K181364 · 2018-06-20
ApplicantE.M.S Electro Medical Systems S.A
Decision Date2018-06-20
Product CodeFEO
Advisory CommitteeGU
DecisionSubstantially Equivalent
Device Summary
Swiss LithoClast Trilogy is a medical device manufactured by E.M.S Electro Medical Systems S.A. It received FDA 510(k) clearance on 2018-06-20 under approval number K181364. The device is classified under product code FEO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Swiss LithoClast Trilogy?
Swiss LithoClast Trilogy is a medical device that received FDA 510(k) clearance on 2018-06-20. It is manufactured by E.M.S Electro Medical Systems S.A. The 510(k) number is K181364.
When was Swiss LithoClast Trilogy approved by the FDA?
Swiss LithoClast Trilogy received FDA 510(k) clearance on 2018-06-20, under approval number K181364.
What company makes Swiss LithoClast Trilogy?
Swiss LithoClast Trilogy is manufactured by E.M.S Electro Medical Systems S.A.
What is the FDA product code for Swiss LithoClast Trilogy?
The FDA product code for Swiss LithoClast Trilogy is FEO.
Other Devices by E.M.S Electro Medical Systems S.A
Related Devices (Code: FEO)
K171024ShockPulse-SE Lithotripsy SystemCybersonics, Inc.
K182490Swiss LithoClast TrilogyE.M.S Electro Medical Systems S.A
K181997Swiss LithoClast TrilogyE.M.S Electro Medical Systems S.A
K173234Swiss LithoClast TrilogyE.M.S Electro Medical Systems S.A
K230893Swiss LthoClast TrilogyE.M.S Electro Medical Systems S.A
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.